Sophia Genetics SA Total Liabilities
Sophia Genetics SA total liabilities. Based on the latest financial reports, Sophia Genetics SA (SOPH) has total liabilities worth $102.77 Million USD as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check Sophia Genetics SA (SOPH) liquid assets ratio to evaluate the company's liquid asset resilience ratio.
Total Liabilities of Sophia Genetics SA (2018–2024)
Total liabilities of Sophia Genetics SA from 2018 to 2024. This chart illustrates how Sophia Genetics SA's total liabilities have evolved over time, based on quarterly financial data. Explore SOPH long-term investment intensity to see how much of total assets are deployed in long-term investments.
Sophia Genetics SA Competitors by Total Liabilities
The table below lists competitors of Sophia Genetics SA ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
A-LIVING SM.CI.SV. H YC 1
F:1V0
|
Germany | €9.07 Billion |
|
Zhejiang XinNong Chemical Co Ltd Class A
SHE:002942
|
China | CN¥451.97 Million |
|
Wonderla Holidays Limited
NSE:WONDERLA
|
India | Rs1.36 Billion |
|
Pinlive Foods Co Ltd
SHE:300892
|
China | CN¥241.21 Million |
|
CJ Corp 4P Pref
KO:00104K
|
Korea | ₩30.66 Trillion |
|
PI Advanced Materials Co. Ltd
KQ:178920
|
Korea | ₩137.93 Billion |
|
Myriad Genetics Inc
NASDAQ:MYGN
|
USA | $335.00 Million |
|
Experian PLC
LSE:EXPN
|
UK | GBX8.71 Billion |
Liability Composition Analysis (2018–2024)
This chart breaks down Sophia Genetics SA's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see Sophia Genetics SA balance sheet assets.
Liquidity & Leverage Metrics
Sophia Genetics SA Total Liabilities Ratios Explained
Sophia Genetics SA total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 2.80 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 1.69 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.63 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Sophia Genetics SA's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Sophia Genetics SA (2018–2024)
The table below shows the annual total liabilities of Sophia Genetics SA from 2018 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | $58.82 Million | +7.50% |
| 2023-12-31 | $54.71 Million | +25.18% |
| 2022-12-31 | $43.71 Million | -2.38% |
| 2021-12-31 | $44.77 Million | +41.66% |
| 2020-12-31 | $31.61 Million | +7.49% |
| 2019-12-31 | $29.40 Million | +34.85% |
| 2018-12-31 | $21.80 Million | -- |
About Sophia Genetics SA
SOPHiA GENETICS SA operates as a cloud-native software technology company in the healthcare space. It offers SOPHiA DDM platform, a cloud-native software platform for analyzing data and generating insights from multimodal data sets and diagnostic modalities. Its SOPHiA DDM platform and related solutions, applications, products, and services are used by hospitals, laboratories, and biopharmaceutic… Read more